They Target 14 Year Olds WHY?

http://www.clinicaltrials.gov


Ages Eligible for Study: 14 Years to 18 Years
Genders Eligible for Study: Female
Accepts Healthy Volunteers: Yes

Criteria

Inclusion Criteria:

Healthy, sexually active females age 14 to 18 who:

Are interested in long term, reversible contraception
Have regular menstrual cycles (21-35 days)
Are not planning a pregnancy within the next 6 months


http://www.clinicaltrials.gov/ct2/results?term=mirena


Found 63 studies with search of: mirena

1 Completed Mirena Efficiency and Tolerability During the First Year of Use
Condition: Contraception
Intervention: Drug: Mirena

2 Active, not recruiting Postplacental or Delayed Insertion of the Levonorgestrel-IUD After Vaginal Delivery
Conditions: Contraception; Postpartum Period; Intrauterine Devices
Intervention: Drug: Levonorgestrel-releasing IUD (Mirena)

3 Recruiting The Effect of a Levonorgestrel-Releasing Intrauterine Device (IUD) Versus a Copper Containing IUD on Risk of Blood Clots
Condition: Blood Coagulation Disorders
Interventions: Device: Levonorgestrel-containing IUD (Mirena®); Device: Copper-containing IUD (Paraguard®)

4 Recruiting Postplacental Insertion of Levonorgestrel-Releasing Intrauterine System (LNG-IUS) After Cesarean vs. Interval Insertion
Condition: Healthy
Interventions: Device: Levonorgestrel-releasing intrauterine system (LNG-IUS); Device: Levonorgestrel-releasing intrauterine system (LNG-IUS)

5 Active, not recruiting Advance Supply of Emergency Contraception Compared to Routine Postpartum Care in Teens
Condition: Post Partum
Intervention: Drug: Plan B (Levonorgestrel)

6 Recruiting Copper T380 IUD and Oral Levonorgestrel for Emergency Contraception vs. Plan B for Emergency Contraception
Condition: Pregnancy
Interventions: Drug: Copper T380 IUD; Drug: levonorgestrel

7 Active, not recruiting Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia
Conditions: Contraception; Menorrhagia
Intervention: Drug: levonorgestrel

8 Active, not recruiting HR-QoL and Sexuality in Mirena Inserted Contraception Users
Condition: Intra-Uterine Contraception
Intervention: Drug: Mirena

9 Active, not recruiting Dose-Comparison Study.
Condition: Contraception
Interventions: Drug: Mirena®; Drug: LCS G04209B, G04209C

10 Recruiting A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication
Conditions: HIV Infections; Contraception; Pharmacokinetics
Intervention: Drug: levonorgestrel, efavirenz

11 Recruiting Maintaining Intrauterine Devices (IUDs) in Teens (MINT): A Randomization Trial
Condition: Contraception
Interventions: Device: Levonorgestrel-releasing intrauterine device (LNG-IUS) - Mirena IUD; Device: Paraguard (Copper T380A)

12 Recruiting Norplant and Irregular Bleeding/Spotting
Conditions: Endometrial Bleeding; Periodontal Disease
Intervention: Drug: doxycycline

13 Recruiting IUD Insertion After D&E Procedure
Condition: Contraception
Intervention: Drug: Levonorgestrel IUD

14 Recruiting A Randomized, Controlled, Comparative Study of a Levonorgestrel Intrauterine System for the Prevention of Endometrial Cancer in Patients Aged 40-50 With BMI Greater Than 35
Condition: Endometrial Cancer
Intervention: Device: Levonorgestrel intrauterine system

15 Completed Study Evaluating Effects of Levonorgestrel and Ethinyl Estradiol on Ovulation
Condition: Ovulation
Interventions: Drug: Levonorgestrel; Drug: Ethinyl Estradiol

16 Active, not recruiting Levonorgestrel Contraceptive Intrauterine Systems (LCS) Pearl Index Study
Condition: Contraception
Interventions: Drug: G04209F; Drug: G04209G

17 Recruiting Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: levonorgestrel; Drug: placebo

18 Completed Effect of an Intrauterine Contraceptive Device (IUD) in HIV Infected Women
Condition: HIV Infections
Intervention: Device: Levonorgestrel-releasing intrauterine device (IUD)

19 Recruiting Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss After Treatment With the Levonorgestrel-Releasing Intrauterine System (IUS)
Condition: Menorrhagia
Interventions: Drug: Levonorgestrel-releasing intrauterine system; Drug: Medroxyprogesterone acetate

20 Completed Randomized Trial of Advanced Provision Emergency Contraception Among Women With Gonorrhea or Chlamydia
Condition: Pregnancy
Intervention: Drug: levonorgestrel 0.75mg taken twice 12 hours apart (Plan B) and condoms

21 Completed Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS
Condition: Premenstrual Syndrome
Intervention: Drug: Levonorgestrel/Ethinyl Estradiol

22 Completed Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder
Conditions: Premenstrual Syndrome; Menstruation Disturbances
Intervention: Drug: Levonorgestrel/Ethinyl Estradiol

23 Not yet recruiting Study Evaluating the Bioequivalence of Levonorgestrel/Ethinyl Estradiol Combinations in Cycling Women
Condition: Contraception
Intervention: Drug: Levonorgestrel/Ethinyl Estradiol

24 Completed Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder
Conditions: Menstruation Disturbances; Premenstrual Syndrome
Intervention: Drug: levonorgestrel/ethinyl estradiol

25 Active, not recruiting Effects of St. John's Wort on the Oral Contraceptive Hormone Levonorgestrel
Condition: Contraception
Intervention: Drug: St. John's wort (Hypericum perforatum)

26 Completed Efficacy Trial of CDB 2914 for Emergency Contraception
Condition: Emergency Contraception
Interventions: Drug: CDB-2914; Drug: levonorgestrel

27 Active, not recruiting Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS) as a Contraceptive to Using it as Part of Hormone Replacement Therapy (HRT).
Condition: Menopause
Intervention: Device: Mirena®

28 Recruiting Intrauterine Levonorgestrel and Observation or Observation Alone in Preventing Atypical Endometrial Hyperplasia and Endometrial Cancer in Women With Hereditary Non-Polyposis Colorectal Cancer or Lynch Syndrome
Conditions: Endometrial Cancer; Hereditary Non-Polyposis Colon Cancer (hmsh2, hmlh1, hpms1, hpms2)
Interventions: Drug: levonorgestrel-releasing intrauterine system; Procedure: observation; Procedure: questionnaire administration

29 Recruiting Case-Control-Study on the Breast Cancer Risk of Mirena® Compared With Other Contraceptive Methods
Condition: Breast Cancer Risk
Intervention:

30 Completed Relative Risks for Non-Fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-Containing Oral Contraceptives.
Conditions: Female Contraception; Contraception; Fertility Control
Intervention:

31 Completed Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception
Condition: Contraception
Intervention: Drug: Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg

32 Completed Study Evaluating Levonorgestrel and Ethinyl Estradiol in Oral Contraception
Condition: Oral Contraceptive
Intervention: Drug: Levonorgestrel 90 mg and Ethinyl Estradiol 20 mg

33 Completed Study Comparing Two Manufacturing Processes for Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg (LNG/EE) in Healthy, Cycling Women
Condition: Healthy
Intervention: Drug: levonorgestrel/ethinyl estradiol

34 Recruiting Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception
Condition: Contraception
Interventions: Drug: CDB-2914; Drug: Levonorgestrel

35 Not yet recruiting Cervical Device Contraception-2 (Nanopaz)
Condition: Healthy
Intervention: Other: Nanopaz contraception device

36 Active, not recruiting Effects on Bone Mineral Density (BMD) of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG/EE
Condition: Contraception
Interventions: Drug: Estradiol and Nomegestrol Acetate Tablets; Drug: Levonorgestrel and Ethinyl Estradiol Tablets

37 Completed Effects of Hormonal Contraceptives on Liver Proteins and Coagulation Factors: A Comparison of a Contraceptive Vaginal Ring and an Oral Contraceptive
Condition: Contraception
Intervention: Drug: Nestorone/ethinyl estradiol contraceptive vaginal ring; levonorgestrel/ethinyl estradiol oral contraceptive

38 Completed A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens
Condition: Healthy
Interventions: Drug: Seasonale [levonorgestrel (LNG)/ethinyl estradiol (EE)]; Drug: Seasonique (LNG/EE and EE); Drug: Portia (LNG/EE)

39 Not yet recruiting The Effectiveness of Lng IUD for Treatment of the Patient Undergone Conservative Surgery for Pelvic Endometriosis
Conditions: Endometriosis; Pelvic Pain; Dysmenorrhea
Intervention: Device: Levonorgestrel IUD

40 Recruiting AZD6140 Oral Contraceptive Interaction Study
Condition: Healthy
Interventions: Drug: AZD6140; Drug: Levonorgestrel and Ethinyl Estradiol (Nordette®)

41 Completed Impact of SH T00658ID as Compared to a Monophasic Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D01155E) on Hemostatic Parameters
Condition: Pregnancy, Unplanned
Intervention: Drug: SH T00658ID

42 Completed Efficacy and Safety Study in Postmenopausal Women to Determine the Lowest Effective Dose for Relief of Moderate to Severe Hot-Flushes
Condition: Hot Flushes
Intervention: Drug: 2.2mg 17 Beta-estradiol/0.69mg levonorgestrel combination transdermal patch and a 1mg 17 Beta-estradiol transdermal patch

43 Completed Human Ovarian Follicular Dynamics and Emergency Contraception
Condition: Contraception
Interventions: Drug: 0.75 levonorgestrel; Drug: 50 mg ethinyl estradiol/0.5 mg levonorgestrel

44 Completed A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
Condition: Dysmenorrhea
Interventions: Drug: levonorgestrel/EE 0.15/0.03 and EE 0.01 mg tablets; Drug: levonorgestrel/EE 0.15/0.03 mg tablets and placebo

45 Completed Oral Contraceptive Efficacy and Body Weight
Conditions: Contraception; Body Weight
Intervention: Drug: ethinyl estradiol / levonorgestrel

46 Completed Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG/EE
Condition: Contraception
Interventions: Drug: Estradiol and Nomegestrol Acetate Tablets; Drug: Levonorgestrel and Ethinyl Estradiol Tablets

47 Not yet recruiting Treatment of Endometrial Hyperplasia With an Intrauterine Device (IUD)
Condition: Endometrial Hyperplasia
Intervention: Device: Intrauterine Device

48 Recruiting Immediate Versus Delayed IUD Insertion Following First Trimester Suction Aspiration Procedures
Condition: Contraception
Intervention: Procedure: Immediate IUD insertion

49 Completed Pearl Index Study With Low Dose Combined Oral Contraceptive
Condition: Contraception
Intervention: Drug: SH D00342A

50 Completed Hormonal Birth Control and the Risk of Acquiring HIV
Condition: HIV Infections
Interventions: Drug: Ethinyl estradiol/levonorgestrel; Drug: Medroxyprogesterone acetate